Mei Lin Wang1, Bipin H Avashia, Edward L Petsonk. 1. Division of Respiratory Disease Studies, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Morgantown, WV 26505, USA.
Abstract
STUDY OBJECTIVE: Spirometry is performed to monitor lung health, but variability between tests can hinder recognition of excessive FEV(1) declines. We sought to describe the relationship between FEV(1) changes over 1 to 5 years and FEV(1) declines over longer terms, using 21,821 test results from 1,884 workers who participated in an annual health monitoring program at a chemical plant between 1973 and 2003. METHODS: Test results from workers with five or more valid results over > or = 10 years were included in our analysis (mean initial worker age, 35 years; range, 18 to 62 years; 91% male; 35% current smokers and 41% nonsmokers). For each worker, long-term FEV(1) slopes (milliliters per year) were calculated by simple linear regression using all available results and compared to changes in FEV(1) between two tests over 1 to 5 years, expressed in both milliliters and percentage of initial value. RESULTS: Long-term (mean, 18 years; range, 10 to 30 years) slopes averaged - 29.1 mL/yr (- 27, - 29, and - 37 mL/yr for male never-smokers, former smokers, and current smokers, and - 20, - 26, and - 27 mL/yr for female never-smokers, former smokers, and current smokers, respectively). Excessive short-term and long-term declines were defined by lower fifth percentile values. Individuals with abnormal short-term declines were found to be 3 to 18 times more likely to ultimately show excessive long-term declines; with the strength of the association increasing with the length of the short-term testing interval. Better test operating characteristics resulted if abnormal short-term FEV(1) change was based on percentage change (ie, percentage per year) rather than absolute change (ie, milliliters per year). CONCLUSIONS: Our findings provide guidance for interpreting periodic spirometry results from individuals exposed to respiratory hazards.
STUDY OBJECTIVE: Spirometry is performed to monitor lung health, but variability between tests can hinder recognition of excessive FEV(1) declines. We sought to describe the relationship between FEV(1) changes over 1 to 5 years and FEV(1) declines over longer terms, using 21,821 test results from 1,884 workers who participated in an annual health monitoring program at a chemical plant between 1973 and 2003. METHODS: Test results from workers with five or more valid results over > or = 10 years were included in our analysis (mean initial worker age, 35 years; range, 18 to 62 years; 91% male; 35% current smokers and 41% nonsmokers). For each worker, long-term FEV(1) slopes (milliliters per year) were calculated by simple linear regression using all available results and compared to changes in FEV(1) between two tests over 1 to 5 years, expressed in both milliliters and percentage of initial value. RESULTS: Long-term (mean, 18 years; range, 10 to 30 years) slopes averaged - 29.1 mL/yr (- 27, - 29, and - 37 mL/yr for male never-smokers, former smokers, and current smokers, and - 20, - 26, and - 27 mL/yr for female never-smokers, former smokers, and current smokers, respectively). Excessive short-term and long-term declines were defined by lower fifth percentile values. Individuals with abnormal short-term declines were found to be 3 to 18 times more likely to ultimately show excessive long-term declines; with the strength of the association increasing with the length of the short-term testing interval. Better test operating characteristics resulted if abnormal short-term FEV(1) change was based on percentage change (ie, percentage per year) rather than absolute change (ie, milliliters per year). CONCLUSIONS: Our findings provide guidance for interpreting periodic spirometry results from individuals exposed to respiratory hazards.
Authors: Eva Hnizdo; Kanta Sircar; Tieliang Yan; Philip Harber; James Fleming; Henry W Glindmeyer Journal: Occup Environ Med Date: 2007-05-03 Impact factor: 4.402
Authors: Rafael E de la Hoz; Xiaoyu Liu; John T Doucette; Anthony P Reeves; Laura A Bienenfeld; Juan P Wisnivesky; Juan C Celedón; David A Lynch; Raúl San José Estépar Journal: Lung Date: 2018-05-24 Impact factor: 2.584
Authors: Kaitlyn G Lawrence; Alexander P Keil; Stavros Garantziotis; David M Umbach; Patricia A Stewart; Mark R Stenzel; John A McGrath; W Braxton Jackson; Richard K Kwok; Matthew D Curry; Lawrence S Engel; Dale P Sandler Journal: J Toxicol Environ Health A Date: 2020-04-05
Authors: Eva Hnizdo; Tieliang Yan; Artak Hakobyan; Paul Enright; Lu-Ann Beeckman-Wagner; John Hankinson; James Fleming; Edward Lee Petsonk Journal: Open Med Inform J Date: 2010-07-08
Authors: Tjard R Schermer; Bas Robberts; Alan J Crockett; Bart P Thoonen; Annelies Lucas; Joke Grootens; Ivo J Smeele; Cindy Thamrin; Helen K Reddel Journal: NPJ Prim Care Respir Med Date: 2016-09-29 Impact factor: 2.871